Patient Guide: Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 6 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07025304
Status: 🟢 Enrolling Now
Condition: Nasal Obstruction, Hypertrophy
Phase: NA

Where You Can Participate

This study is available at 6 locations across the country.

Top locations include:
  • • Guangzhou, Guangdong
  • • Guangzhou, Guangdong
  • • Zhengzhou, Henan
  • • And 3 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China - Join Clinical Trial NCTNCT07025304

How to Join This Clinical Trial - NCTNCT07025304

Learn how to participate in this NA trial studying an investigational therapy for Nasal Obstruction, Hypertrophy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Nasal Obstruction, Hypertrophy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Nasal Obstruction, Hypertrophy
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07025304 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 6 locations. Find a study site near you:

Clinical Research Site

Guangzhou, Guangdong 510080 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Guangzhou, Guangdong 510630 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Zhengzhou, Henan 462000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210003 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Changchun, Jilin 130033 - China

Status: RECRUITING

Clinical Research Site

Hangzhou, Zhejiang 310016 - China

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Nasal Obstruction, Hypertrophy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships